Vanina de Verneuil's most recent trade in Vir Biotechnology Inc was a trade of 7,373 Common Stock done at an average price of $9.1 . Disclosure was reported to the exchange on Feb. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 9.14 per share. | 26 Feb 2025 | 7,373 | 79,460 (0%) | 0% | 9.1 | 67,402 | Common Stock |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 35,000 | 91,973 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 22 Feb 2025 | 5,140 | 86,833 (0%) | 0% | 9.5 | 48,590 | Common Stock |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | 02 Dec 2024 | 76 | 56,973 (0%) | 0% | 8.2 | 625 | Common Stock | |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | 06 Nov 2024 | 4,397 | 56,973 (0%) | 0% | 10.1 | 44,454 | Common Stock | |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | 01 Nov 2024 | 2,347 | 61,370 (0%) | 0% | 9.5 | 22,225 | Common Stock | |
| Vir Biotechnology Inc | Vanina de Verneuil | EVP and General Counsel | 01 Nov 2024 | 1,403 | 63,717 (0%) | 0% | 7.2 | 10,107 | Common Stock |